Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Incidence of irritable bowel syndrome and functional bowel disorders after bacillary dysentery

The incidence of irritable bowel syndrome and functional bowel disorders after bacillary dysentery has been evaluated in a study published in the latest edition of the journal Gut.

News image

fiogf49gjkf04

Professor G-Z Pan and colleagues from the Department of Gastroenterology at the Chinese Academy of Medical Sciences in Beijing, China, were interested to find out more about the pathogenesis of post-infective irritable bowel syndrome (IBS), about which little is known.

Therefore, they investigated the incidence of IBS and functional bowel disease (FBD) in a Chinese patient population who had recovered from bacillary dysentery.

They also examined the relationship between mast cells and intestinal nerves, as well as examining neuroimmunological changes in interleukins, mast cells and neuropeptides, in order to further understand its pathogenesis.

The researchers studied a cohort of 295 patient who had recovered from bacillary dysentery, 71.4% of whom had shigella identified from stool samples, as well as 243 control subjects. These consisted of patient siblings or spouses who had not been infected with bacillary dysentery.

Using questionnaires, all subjects were followed-up for 1 to 2 years in order to identify the incidence of FBD and IBS, as defined by the Rome II criteria.

Bacillary dysentery is a causative factor in post-infective IBS
Gut

In 56 cases of IBS, both post-infective and non post-infective, the numbers of mast cells in biopsy specimens from the intestinal mucosa were counted under light microscopy, following staining with anti-tryptase antibody.

In addition, the relationship of mast cells to neurone specific enolase (NSE), substance P (SP), 5-hydroxytryptamine (5-HT), or calcitonin gene related peptide positive nerve fibers was observed using double staining with alcian blue and neuropeptide antibodies.

In 30 cases of IBS (half of which were post-infective), taken randomly from the 56 cases of IBS in total, expression of interleukin (IL)-1, IL-1ß, and IL-1 receptor antagonist (IL-1ra) mRNAs in intestinal mucosa were identified using reverse transcription-polymerase chain reaction.

All the results were compared with 12 non-IBS controls.

The results showed that in the group of bacillary dysentery-infected patients, the incidences of FBD and IBS were 22.4% and 8.1%. In those who had provided stool samples positive for shigella, the incidence of IBS rose to 10.2%.

In the control group the levels of FBD and IBS were considerably lower, at 7.4% and 0.8% respectively.

The researchers found that a longer duration of diarrhea (7 days) was associated with a higher risk of developing FBD, while expression of IL-1ß mRNA in the terminal ileum and rectosigmoid mucosa was significantly higher in post-infective IBS patients.

The number of mast cells in the terminal ileum mucosa in post-infective IBS (11.19) and non-post-infective IBS patients (10.78) was significantly increased compared with that in control subjects (6.05).

Also, in the terminal ileum and rectosigmoid mucosa of IBS patients, the density of NSE, SP, and 5-HT positively stained nerve fibers increased and appeared in clusters, surrounding an increased number of mast cells compared with controls.

Commenting on their findings, Professor Pan said they showed that bacillary dysentery is a causative factor in post-infective IBS. He added that both the immune system and the nervous system may play important roles in the pathogenesis of post-infective IBS.

Gut 2004; 53 (8): 1096 - 1101
15 July 2004

Go to top of page Email this page Email this page to a colleague

 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 21 November 2017 
Prepregnancy obesity and maternal mortality
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us